Publications by authors named "Frederic Thuaud"

Claim this Profile
S
Synthesis of All Stereoisomers of Monomeric Spectomycin A1/A2 and Evaluation of Their Protein SUMOylation-Inhibitory Activity.
Yusaku Nomura, Frédéric Thuaud, Daisuke Sekine, Akihiro Ito, Satoko Maeda

Chemistry· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporation of Acid-Labile Masking Groups for the Traceless Synthesis of C-Terminal Peptide α-Ketoacids.
Frédéric Thuaud, Florian Rohrbacher, André Zwicky, Jeffrey W Bode

Org Lett· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical Synthesis of the 20 kDa Heme Protein Nitrophorin 4 by α-Ketoacid-Hydroxylamine (KAHA) Ligation.
Chunmao He, Sameer S Kulkarni, Frédéric Thuaud, Jeffrey W Bode

Angew Chem Int Ed Engl· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of flavaglines as potential chikungunya virus entry inhibitors.
Phitchayapak Wintachai, Frédéric Thuaud, Christine Basmadjian, Sittiruk Roytrakul, Sukathida Ubol

Microbiol Immunol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KAHA ligations that form aspartyl aldehyde residues as synthetic handles for protein modification and purification.
Claudia E Murar, Frédéric Thuaud, Jeffrey W Bode

J Am Chem Soc· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
Lise Boussemart, Hélène Malka-Mahieu, Isabelle Girault, Delphine Allard, Oskar Hemmingsson, Frédéric Thuaud

Nature· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzofuran derivatives as anticancer inhibitors of mTOR signaling.
Christophe Salomé, Nigel Ribeiro, Thierry Chavagnan, Frédéric Thuaud, Maria Serova

Eur J Med Chem· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective anticancer effects of a synthetic flavagline on human Oct4-expressing cancer stem-like cells via a p38 MAPK-dependent caspase-3-dependent pathway.
Fathi Emhemmed, Sarah Ali Azouaou, Frédéric Thuaud, Valérie Schini-Kerth, Laurent Désaubry

Biochem Pharmacol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RE12 derivatives displaying Vaccinia H1-related phosphatase (VHR) inhibition in the presence of detergent and their anti-proliferative activity against HeLa cells.
Frédéric Thuaud, Shuntaro Kojima, Go Hirai, Kana Oonuma, Ayako Tsuchiya

Bioorg Med Chem· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzofuran derivatives as a novel class of inhibitors of mTOR signaling.
Christophe Salomé, Vanessa Narbonne, Nigel Ribeiro, Frédéric Thuaud, Maria Serova

Eur J Med Chem· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A.
Christine Basmadjian, Frédéric Thuaud, Nigel Ribeiro, Laurent Désaubry

Future Med Chem· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prohibitin ligands in cell death and survival: mode of action and therapeutic potential.
Frédéric Thuaud, Nigel Ribeiro, Canan G Nebigil, Laurent Désaubry

Chem Biol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-[3a-(4-Bromo-phen-yl)-8b-hy-droxy-6,8-dimeth-oxy-3-phenyl-2,3,3a,8b-tetra-hydro-1H-cyclo-penta-[b]benzofuran-1-yl]formamide monohydrate.
Emmanuel Aubert, Frédéric Thuaud, Nigel Ribeiro, Laurent Désaubry, Enrique Espinosa

Acta Crystallogr Sect E Struct Rep Online· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flavaglines as potent anticancer and cytoprotective agents.
Nigel Ribeiro, Frédéric Thuaud, Yohann Bernard, Christian Gaiddon, Thierry Cresteil

J Med Chem· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2.
Gernot Polier, Jennifer Neumann, Frédéric Thuaud, Nigel Ribeiro, Christoph Gelhaus

Chem Biol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27.
Yohann Bernard, Nigel Ribeiro, Frédéric Thuaud, Gülen Türkeri, Ronan Dirr

PLoS One· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in the biology and chemistry of the flavaglines.
Nigel Ribeiro, Frédéric Thuaud, Canan Nebigil, Laurent Désaubry

Bioorg Med Chem· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel flavaglines displaying improved cytotoxicity.
Frédéric Thuaud, Nigel Ribeiro, Christian Gaiddon, Thierry Cresteil, Laurent Désaubry

J Med Chem· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic analogue of rocaglaol displays a potent and selective cytotoxicity in cancer cells: involvement of apoptosis inducing factor and caspase-12.
Frédéric Thuaud, Yohann Bernard, Gülen Türkeri, Ronan Dirr, Geneviève Aubert

J Med Chem· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis